Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Quantitative analysis of SHBG glycosylation in liver diseases by LC/MS-PRM

ABSTRACT: To explore the association of SHBG glycoforms with liver disease of different etiologies, SHBG was enriched by immunoaffinity approach from sera of patients and healthy controls. The enriched SHBG was digested by trypsin alone or with the combination of Neuraminidase A. Quantitative analysis of SHBG glycosylation microheterogeneity were performed by LC/MS-PRM method.

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Radoslav Goldman

PROVIDER: PXD010204 | JPOST Repository | Sun Jun 23 00:00:00 BST 2019

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	20170928-HCV1-5ul.wiff.scan	Wiff
	20170928-HCV2-3ul.wiff	Wiff
	20170928-HCV2-3ul.wiff.scan	Wiff
	20170930-Alcohol1-4ul.wiff	Wiff
	20170930-Alcohol1-4ul.wiff.scan	Wiff

Items per page:

1 - 5 of 20

Similar Datasets

Defective N-Glycosylation of IL6 Induces Metastasis and Tyrosine Kinase Inhibitor Resistance in Lung Cancer

Project description:The biological consequences of various IL-6 glycoforms are unknown. To uncover the function of N-glycosylation of IL-6 in lung cancer, we compare the gene expression profiles in NSCLC cells induced by conditioned medium containing IL-6 with complete N-glycosylation (NG-IL6) or defective N-glycosylation (deNG-IL6).

2024-07-16 | GSE269782 | GEO

PRM analysis of C-glycosylation substrate

Project description:To assess the impact of mutations on CMT activity C-glycosylation within RNase E was monitored using PRM analysis.

2022-11-01 | PXD032391 | Pride

Providencia alcalifaciens strain:PRM-2

Project description:Providencia alcalifaciens strain:PRM-2 Genome sequencing and assembly

| PRJNA437544 | ENA

Site-specific N- and O-glycosylation Analysis of Human Plasma Fibronectin

Project description:Human plasma fibronectin is an adhesive protein that plays a crucial role in wound healing. Many studies had indicated that glycans may mediate the expression and functions of fibronectin, yet a comprehensive understanding of its glycosylation is still missing. Here, we performed a comprehensive N- and O-glycosylation mapping of human plasma fibronectin, and quantified the occurrence of each glycoform in a site-specific manner. Intact N-glycopeptides were enriched by zwitterionic hydrophilic interaction chromatography, and N-glycosites sites were localized by the 18O-labeling method. O-glycopeptide enrichment and O-glycosite identification were achieved by an enzyme-assisted site-specific extraction method. An RP–LC–MS/MS system functionalized with Collision-Induced Dissociation and stepped normalized collision energy (sNCE)-HCD tandem mass was applied to analyze the glycoforms of fibronectin. A total of 6 N-glycosites and 53 O-glycosites were identified, which were occupied by 3842 N-glycoforms and 16 O-glycoforms, respectively. Furthermore, 81.4% of N-glycans were either fucosylated, sialylated, or with both modifications77.31% of N-glycans were sialylated, while O-glycosylation was dominated by the sialyl-T antigen. These site-specific glycosylation patterns on human fibronectin can facilitate functional analyses of fibronectin and therapeutics development.

2022-02-17 | PXD025886 | Pride

Identification and relative quantification of hFSH glycoforms in women sera by PRM MS based approach.

Project description:This study presents an alternative preliminary strategy to identify and quantify serum hFSH glycoforms based on immunopurification assay and mass spectrometry (MS) using parallel reaction monitoring (PRM) analysis. In this study, we provide MS-PRM data acquisition method for hFSH glycopeptides identification with high specificity and their quantification by extracting the chromatographic traces of selected fragments of glycopeptides. Once set up in all its features, the proposed method could be transferred to the clinic to improve the fertility treatments and follow-ups in men and women.

2021-06-15 | PXD025585 | Pride

RNA-Seq analysis of glycosylation related gene expression in STZ-induced diabetic rat kidney inner medulla

Project description:The UT-A1 urea transporter is crucial to the kidney’s ability to generate concentrated urine. Native UT-A1 from kidney inner medulla (IM) is a heavily glycosylated protein with two glycosylation forms of 97 and 117 kDa. In diabetes, UT-A1 protein abundance, particularly the 117 kD isoform, is significantly increased corresponding to an increased urea permeability in perfused IM collecting ducts, which plays an important role in preventing the osmotic diuresis caused by glucosuria. In this study, using sugar-specific binding lectins, we found that the carbohydrate structure of UT-A1 is also changed under diabetic conditions with increased amounts of sialic acid, fucose, and increased glycan branching. These changes were accompanied by altered UT-A1 association with the galectin proteins, α-galactoside glycan binding proteins. To explore the molecular basis of the alterations of glycan structures, the highly sensitive next generation sequencing (NGS) technology, Illumina RNA-seq, was employed to analyze genes involved in the process of UT-A1 glycosylation using streptozotocin (STZ) - induced diabetic rat kidney as the tissue source. Differential expression analysis combining quantitative PCR revealed that a number of important glycosylation related genes were changed under diabetic conditions. These genes include the glycosyltransferase genes Mgat4a, the sialylation enzymes St3gal1 and St3gal4and glycan binding protein galectin-3, -5, -8 and -9. In contrast, although highly expressed in kidney IM, the glycosyltransferase genes Mgat1, Mgat2, and fucosyltransferase Fut8, did not show any changes. We conclude that the alteration of these glycosylation related genes may contribute to changing the UT-A1 glycan structure, and therefore modulate kidney urea transport activity under diabetic conditions.

2017-02-09 | GSE69548 | GEO

O-GlcNAcylation Modulates Expression and Abundance of N-Glycosylation Machinery in an Inherited Glycosylation Disorder

Project description:Much of the N-glycosylation machinery was identified decades ago, but the regulatory mechanisms influencing normal and disease states are only beginning to be discovered. Recent studies highlight a role for key metabolites and metabolic enzymes in this process, revising the view of the relationship between different metabolic pathways. Using a multi-omic approach in a zebrafish, we discovered a mechanism where O-GlcNAcylation directly influences the expression and abundance of two enzymes essential for the earliest steps of N-linked glycosylation, the nus1-encoded NgBR and Dpagt1. Here we show that phosphomannomutase (pmm2) deficiency is associated with increased levels of UDP-GlcNAc and protein O-GlcNAcylation. Biochemical studies show that O-GlcNAc modification of the NgBR and Dpagt1 increases their abundance in pmm2m/m mutants. Modulating O-GlcNAc levels, NgBR abundance or Dpagt1 activity exacerbated cartilage phenotypes in pmm2 mutants, suggesting that O-GlcNAc mediated increases in the N-glycosylation machinery protects against more severe pathology. These findings highlight nucleotide-sugar donors as metabolic sensors that coordinate two different glycosylation pathways, demonstrating how their interplay is relevant to disease outcome in the most common congenital disorder of glycosylation.

2024-12-27 | GSE269074 | GEO

Pilot project to determine optimal bioreactor protein glycosylation conditions

Project description:These research areas concentrate on stress induced proteases in recombinant Escherichia coli, glycosylation heterogeneity due to bioprocess conditions produced in mammalian cells, and metabolic engineering of E. coli. The hypothesis of this project is that recombinant protein glycosylation is inefficient under normal bioreactor conditions since the additional glycosylation reactions necessary for the recombinant protein exceed the metabolic capacity of the cells. Normal bioreactor conditions have been optimized for cell growth, and sometimes for protein productivity. Only recently has it been accepted that optimal glycosylation may not occur under optimal growth or protein productivity conditions. Specific Aim: Determine the relationship between bioreactor conditions and glycosylation gene expression in NS0 cells.

2011-04-29 | GSE28920 | GEO

Human serum glycosylation

Project description:In this work, we presented an integrated workflow for simultaneous analysis of sialylated glycosites and site-specific glycoforms by taking advantages of SGP enrichment approach with high specificity and paired spectra intact glycopeptide identification strategy with high efficiency. By using this strategy, comprehensive analysis of sialylation of glycoproteins was achieved, which could reveal the high heterogeneity of sialylated glycosylation. Additionally, significant changes were obtained on the levels of sialylated glycosites, as well as site-specific glycoforms between pooled hepatocellular carcinoma (HCC) and normal human serum samples. Taken together, our method could be a powerful tool for comprehensive analysis of sialylation glycosylation in human serum and other biological samples.

2018-05-03 | PXD009654 |

Integrated profiling of proteins, glycoforms and mRNA in single cells reveals dynamic glycan remodeling during T cell differentiation

Project description:Protein glycosylation is a critical post-translational modification that plays vital roles in cellular function and disease, including infection, autoimmunity and cancer. Techniques that measure specific glycosylated proteins face challenges in sensitivity and throughput, preventing applications in single cells. We introduce Glycan Proximity Sequencing (GPS) for the integrated profiling of proteins, glycosylation and protein-specific glycoforms, as well as mRNA in single cells. GPS achieves affinity-based detection of proteins and their modifications via proximity-based single-cell RNA sequencing. Experiments using mixtures of T and B cells, together with a GnTI-knockout mutant, demonstrated sensitive detection of both global and protein-specific glycosylation differences. Applied to human peripheral blood mononuclear cells, GPS revealed dynamic glycan remodeling patterns during T cell differentiation and potential galectin-binding glycoproteins for modulating immune responses. Notably, we identified a new CD45:LELhigh subcluster of terminally differentiated effector memory CD8+ T cells that are enriched for poly-LacNAc and 2,3-sialylation modifications and associated with exhaustion and susceptibility to galectin-1–induced apoptosis. GPS also captured glycosylation changes in response to perturbations like sialidase treatment and T cell activation. GPS is a scalable and sensitive platform for single-cell glycoproteomics and protein-specific biomarker discovery, and it can reveal mechanistic insights on the role of glycosylation in T cell differentiation.

2025-09-07 | GSE307239 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data